Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- 15 June 2007
- journal article
- Published by Wiley in Hepatology Research
- Vol. 37 (10), 787-792
- https://doi.org/10.1111/j.1872-034x.2007.00132.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levelsHepatology Research, 2005
- Effectiveness of interferon α-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practiceClinical Gastroenterology and Hepatology, 2004
- A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis CHepatology, 2001
- Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune GlobulinNew England Journal of Medicine, 1999
- Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Correction With Proportional Hazard AnalysisHepatology, 1999
- Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort StudyHepatology, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994